Feed ADTX
AD

Aditxt, Inc. ADTX · OTC

$0.00 -33.33% (-$0.00)

Market cap
$598.8K
Enterprise value
$4.56M
P/E
-
Forward P/E
-
PEG
-
P/S
41.8x
P/FCF
-
EV/EBITDA
-
ROIC
-406.3%
Bruto marža
19.9%
Neto marža
-362,386.0%
Dividend yield
-
Payout ratio
-
Neto dolg/EBITDA
-
Beta
0.93
Free float
0.0%

O podjetju

Aditxt, Inc. (ADTX) is a biotechnology company specializing in the development of innovative therapeutic and diagnostic technologies in the fields of immunology and biomedicine. The company focuses on developing products that can enhance patients' immune systems and improve their health. Aditxt develops diagnostic tools that allow for precise monitoring of immune responses and patients' health status. With the growing emphasis on personalized medicine and advanced diagnostic technologies, Aditxt, Inc. has the potential for sustained growth. Aditxt, Inc. (ADTX) shares might be an interesting choice for investors seeking involvement in the biotechnology and innovative diagnostic therapies industry.

Sector

Healthcare

Industry

Biotechnology

CEO

Jeffrey Busch

Employees

26

Headquarters

Mountain View

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe.